Wells Fargo & Company MN Has $551,000 Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Wells Fargo & Company MN raised its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 36.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 74,731 shares of the company’s stock after buying an additional 19,869 shares during the period. Wells Fargo & Company MN’s holdings in LifeStance Health Group were worth $551,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Principal Financial Group Inc. raised its stake in shares of LifeStance Health Group by 6.1% in the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock worth $28,817,000 after purchasing an additional 235,316 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of LifeStance Health Group by 13.0% in the third quarter. JPMorgan Chase & Co. now owns 94,636 shares of the company’s stock valued at $662,000 after purchasing an additional 10,894 shares during the last quarter. SG Americas Securities LLC raised its holdings in shares of LifeStance Health Group by 65.7% in the fourth quarter. SG Americas Securities LLC now owns 90,355 shares of the company’s stock valued at $666,000 after purchasing an additional 35,823 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after acquiring an additional 2,122 shares in the last quarter. Finally, R Squared Ltd bought a new position in LifeStance Health Group in the 4th quarter valued at $80,000. 85.50% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on LFST shares. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They issued a “buy” rating and a $8.00 price objective on the stock. Finally, KeyCorp began coverage on shares of LifeStance Health Group in a research note on Tuesday, April 8th. They set an “overweight” rating and a $9.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, LifeStance Health Group currently has an average rating of “Moderate Buy” and an average price target of $8.30.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now directly owns 339,810 shares in the company, valued at $2,344,689. This represents a 5.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 6.60% of the stock is owned by corporate insiders.

LifeStance Health Group Stock Up 4.3 %

LFST stock opened at $6.80 on Friday. The stock has a 50-day simple moving average of $6.88 and a two-hundred day simple moving average of $7.29. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61. The firm has a market capitalization of $2.64 billion, a PE ratio of -26.15 and a beta of 1.30. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.